A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
To determine whether HMG-CoA reductase inhibitor simvastatin prevents or ameliorates subarachnoid hemorrhage-induced delayed vasospasm and its ischemic consequences.
Epistemonikos ID: 4d2f9e1bce9ed634d7483238cecd9d50536ccf5a
First added on: May 04, 2024